QIAGEN N.V. (QGEN) recently lauded the new guidelines in the United States that recommend screening at- risk children of all ages for latent tuberculosis (TB) infection with modern blood-based tests such as QuantiFERON-TB Gold Plus (QFT-Plus). The latest guidelines from the American Academy of Pediatrics (AAP) highlight testing for TB with modern interferon-gamma release assays (IGRAs). With this development, the company aims for its market-leading QFT-Plus to be a gold standard for blood-based tuberculosis ...